ArticleFrontiers in oncology2025
Unveiling new insights: a comprehensive questionnaire-based single-center study of sebaceous nevus.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Sebaceous nevus (SN) is a rare, benign, congenital tumor. There is limited information on its clinical features, familial influences, quality of life (QoL) impact, and treatment outcomes in Chinese patients. This study aimed to comprehensively examine these aspects. Methods: A questionnaire-based survey was conducted among patients with SN who visited the Department of Plastic Surgery at Shanghai Ninth People's Hospital between January 2018 and December 2023. Healthy control children were recruited using the 'best friends' principle to assess familial influences. QoL impact was measured using the Children's Dermatology Life Quality Index (CDLQI). Results: Our analysis revealed that the severity of skin-related symptoms correlated with the extent of hyperplasia and lesion size. Maternal factors during pregnancy-including medication use, secondhand smoke exposure, toxic chemical contact, and illness (notably COVID-19 infection)-were significantly associated with a higher incidence of SN. Most patients reported a mild to moderate QoL impact. Surgical treatment demonstrated higher satisfaction rates compared to laser therapy. Discussion: These findings suggest that hyperplasia and lesion size may predict symptom severity. The observed association between maternal COVID-19 infection and the occurrence of SN warrants further investigation. Surgical intervention appears to be an effective treatment, particularly for easily removable lesions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.